The startup manufactures the eCG hormone, used to stimulate estrus and ovulation in cows and gilts for artificial insemination, through recombinant protein expression techniques. The marketed hormone has a lower production cost than its competitors and does not inflict suffering to animals, compared to the traditional approaches used.
BUSINESS MODEL: B2B and B2C
STAGE: Commercial approval
For further information, please contact us.
Back to Investors page